DOT Extends Deadline on Portable Oxygen Concentrators. In October, the Department of Transportation (DOT) announced that it was extending the public comment period on air travel with oxygen and other respiratory assistive devices until January 30, 2006.
As you may recall, DOT has issued a proposal to require airlines to allow the use of portable oxygen concentrators during flight by patients. The rule builds on the final rule issued by the Federal Aviation Administration that allows airlines to permit the use of portable oxygen concentrators by travelers.
The extended comment period will likely be used by the patient and physician community to generate additional public comments supporting the use of portable oxygen concentrators during air travel. To date, the patient community has generated over 1,000 comments encouraging DOT to make portable oxygen concentrators available for air travel.
The American Thoracic Society will submit comments on the DOT proposal rule. Those comments will strongly encourage the DOT to make travel convenient and widely available for patients on supplemental oxygen.
In a related story, three major US-based airlines have announced policy that will allow patients to use portable oxygen concentrators (POCs) during flight. America West, US Airways and Northwest Airlines have all posted information regarding use of approved POCs during flight.
America West has announced it will allow the Inogen One
and the AirSep Lifestyle to be used during flight. For further information,
US Airways announced that it will allow both the Inogen
One and the AirSep Lifestyle on all US Airways mainline and code share aircraft.
However, these devices may not be used on US Airways Express flights. For
additional information, please see:
Northwest Airlines has announced that it will allow the
Inogen One system on its flights. They indicated they are still doing additional
testing on the AirSep model. For more information, please see:
The American Thoracic Society (ATS) and the American Lung Association (ALA) maintain a joint Washington Office to advocate on legislative and regulatory issues. The Washington Office is the hub of a nationwide Legislative Network that enables state and local ATS and ALA volunteers, members and staff to participate in grassroots advocacy on public policy initiatives. To keep ATS and ALA advocates informed, we provide regularly updated Public Policy Briefs; publish a weekly newsletter, The Washington Letter and communicate via mail, fax and e-mail when immediate action is needed. We also maintain two advocacy web sites at http://www.lungusa.org and http://www.thoracic.org. You also may contact us at 202/785-3355 or fax us at 202/452-1805.
Please do not reply to this e-mail as the sender address is not monitored.
Should you wish not to receive our e-Newsletter, please send an e-mail to email@example.com to unsubscribe. Please allow up to 72 hours to remove your e-mail address from our data base.
Click the following link to access our newsletter catalog. From this page you will be able to access all the available newsletters both in HTML and PDF (Adobe's Portable Document Format).
To access the print-equivalent Newletter in PDF you will need to download and install the Adobe PDF Reader. You can access the free download site of Adobe by clicking this icon
Regarding any other issue please send an e-mail to firstname.lastname@example.org